Sometimes a study comes along that shows some amazing results and one published in The Lancet does just that.
The study - which looked at people aged between 30 and 85 who were overweight or had obesity - has found a "globally available, low-cost, and safe" diabetes drug called metformin could drastically reduce the instances of long COVID by 40 per cent.
Sadly they didn't find the same results with ivermectin (and they looked).
So what could be going on? How could this old drug be so good at what it's doing? And how could this drug be used to help bring down long COVID cases?
That's on this week's Coronacast - along with a clarification of NSW hospital data and antiviral prescriptions.
Or watch us on YouTube here
Yes, you can get long COVID if you're triple vaxxed
5000 deaths this year and counting
The sub-variants just keep coming
How long can any country stay COVID zero?
Our first proper flu AND covid season looms
When two variants become one
Wasn't the peak meant to be in January?
BONUS: Introducing Australia, If You're Listening
What will winter bring as the sibling of Omicron rises?
How many people had COVID before me?
What's COVID doing to your brain?
Rethinking the lab escape theory
Australia is one again! So how are we tracking?
Are kids getting vaccinated too slowly?
How wars can supercharge pandemics
Restrictions finally easing up. Are they gone for good?
I'm worried about how worried I am
Exponential growth gets there eventually
Four scenarios for the pandemic's next phase
How do we sidestep the next pandemic?
Create your
podcast in
minutes
It is Free
Newscast
Consider This from NPR
Chasing Life
The Coronavirus Podcast
Up First